Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Di(Hydroxyethyl)Ether SCHEMBL5313479 | 0.98 | ALDH1A1 (0.46) | ALDH1A1TSHRMEN1KMT2AMAPK1 | |
| Ethylene Glycol SCHEMBL5313359 | 0.87 | ALDH1A1 (0.47) | ALDH1A1TSHRMAPK1SMN1; SMN2TDP1 | |
| 1,4-Butanediol SCHEMBL21772254 | 0.83 | ALDH1A1 (0.44) | ALDH1A1TSHRMAPK1SMN1; SMN2TDP1 | |
| SCHEMBL207666 | 0.82 | — | — | |
| Triethylene Glycol SCHEMBL5922889 | 0.82 | ALDH1A1 (0.48) | ALDH1A1TSHRMEN1KMT2AMAPK1 | |
| Ethylene Glycol SCHEMBL5420838 | 0.81 | ALDH1A1 (0.42) | ALDH1A1TSHRMAPK1SMN1; SMN2TDP1 | |
| Glycidol SCHEMBL21055879 | 0.81 | ALDH1A1 (0.45) | ALDH1A1TSHRMAPK1SMN1; SMN2TDP1 | |
| Triethylene Glycol SCHEMBL5922895 | 0.81 | TSHR (0.50) | ALDH1A1TSHRMEN1KMT2AMAPK1 | |
| Triethylene Glycol SCHEMBL5318035 | 0.81 | ALDH1A1 (0.72) | ALDH1A1TSHRMEN1KMT2AMAPK1 | |
| SCHEMBL8191937 | 0.81 | TSHR (0.60) | ALDH1A1TSHRMEN1KMT2AMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112470318-B | Electrolyte composition, electrolyte membrane, and method for producing electrolyte membrane | 株式会社日本触媒 | 2024-08-16 | — | — | CN | disclosed |
| US-12027666-B2 | Electrolyte composition, electrolyte film, and method of manufacturing electrolyte film | NIPPON SHOKUBAI CO., LTD. (JP) | 2024-07-02 | — | — | US | disclosed |
| WO-2024135615-A1 | ELECTROLYTE COMPOSITION, ELECTROLYTE CURED ARTICLE OBTAINED BY CURING SAME, ELECTRODE, AND SECONDARY BATTERY | 株式会社日本触媒 | 2024-06-27 | — | — | WO | disclosed |
| WO-2024024628-A1 | METHOD FOR PRODUCING BATTERY CONSTITUENT MATERIAL AND ELECTRODE | 株式会社日本触媒 | 2024-02-01 | — | — | WO | disclosed |
| WO-2024024624-A1 | COMPOSITION AND SLURRY, BATTERY CONSTITUENT MATERIAL USING SAME, AND ELECTRODE AND ALL-SOLID-STATE BATTERY | 株式会社日本触媒 | 2024-02-01 | — | — | WO | disclosed |
| EP-3817119-B1 | ELECTROLYTE COMPOSITION, ELECTROLYTE FILM, AND METHOD OF MANUFACTURING ELECTROLYTE FILM | NIPPON CATALYTIC CHEM IND (JP) | 2022-08-17 | — | — | EP | disclosed |
| CN-111996563-B | Hole metallization composition for vertical continuous pulse electroplating and electroplating method | 广东硕成科技股份有限公司 | 2022-07-01 | — | — | CN | disclosed |
| US-11374258-B2 | Electrolyte composition, electrolyte membrane, electrode, cell and method for evaluating electrolyte composition | NIPPON SHOKUBAI CO., LTD. (JP) | 2022-06-28 | — | — | US | disclosed |
| EP-3648226-B1 | ELECTROLYTE COMPOSITION, ELECTROLYTE MEMBRANE, ELECTRODE AND BATTERY | NIPPON CATALYTIC CHEM IND (JP) | 2022-06-22 | — | — | EP | disclosed |
| US-11342583-B2 | — | — | 2022-05-24 | — | — | US | disclosed |
| EP-1251118-B1 | UNSATURATED MONOCARBOXYLIC ESTER COMPOUND, PROCESS FOR PRODUCING THE SAME, AND COMPOSITION CURABLE WITH ACTINIC ENERGY RAY | UNIV KANAGAWA (JP) | 2006-12-20 | — | — | EP | disclosed |
| US-7057063-B2 | Unsaturated carboxylic ester compound, process for producing the same, and composition curable with actinic energy ray | KANAGAWA UNIVERSITY (JP) | 2006-06-06 | — | — | US | disclosed |
| US-20060030636-A1 | Unsaturated carboxylic ester compound, process for producing the same, and composition curable with actinic energy ray | KANAGAWA UNIVERSITY | 2006-02-09 | — | — | US | disclosed |
| US-20050197485-A1 | Process for production of ethylene oxide copolymer | NIPPON SHOKUBAI CO., LTD. | 2005-09-08 | — | — | US | disclosed |
| EP-1568726-A1 | Process for production of ethylene oxide copolymer | Nippon Shokubai Co., Ltd. (JP) | 2005-08-31 | — | — | EP | disclosed |
| US-6864353-B2 | Production process for ethylene oxide copolymer | DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) | 2005-03-08 | — | — | US | disclosed |
| US-20030158374-A1 | Production process for ethylene oxide copolymer | DAI-ICHI KOGYO SEIYAKU CO., LTD. | 2003-08-21 | — | — | US | disclosed |
| EP-1327650-A1 | Production process for ethylene oxide copolymer | Dai-Ichi Kogyo Seiyaku Co., Ltd. (JP) | 2003-07-16 | — | — | EP | disclosed |
| US-20030009053-A1 | Unsaturated monocarboxylic ester compound, process for producing the same, and composition curable with actinic energy ray | KANAGAWA UNIVERSITY (JP) | 2003-01-09 | — | — | US | disclosed |
| EP-1251118-A1 | UNSATURATED MONOCARBOXYLIC ESTER COMPOUND, PROCESS FOR PRODUCING THE SAME, AND COMPOSITION CURABLE WITH ACTINIC ENERGY RAY | Kanagawa University (JP) | 2002-10-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030009053-A1 | Unsaturated monocarboxylic ester compound, process for producing the same, and composition curable with actinic energy ray | ACSL1, ACSL6, ACSL4 | ALDH1A1 585/4885TSHR 4262/4885MEN1 1009/4885 |
| US-20060030636-A1 | Unsaturated carboxylic ester compound, process for producing the same, and composition curable with actinic energy ray | ACSL1, ACSL6, ACSL3 | ALDH1A1 467/4885TSHR 3538/4885MEN1 1045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.